Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-21

Clinical Trial Update: Shenfu Injection Improves Arterial Vascular Reactivity [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates suggest Shenfu Injection may improve arterial vascular reactivity in septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shenfu Injection

Snippet

Sponsor: Jianfeng Xie | Conditions: Septic Shock, Shenfu | Phase 2, Phase 3 | Status: UNKNOWN